CellWell record HH-76284
Gut microbiome and bile acid metabolism in liver disease: Mechanisms, clinical implications, and therapeutic opportunities
Huiping Zhou; Yi Huang; Chen Chen; Meiyi Song; Phillip B Hylemon
2026
In plain language
This review integrates hepatic bile acid synthesis, enterohepatic circulation and microbial transformation across steatotic, alcohol-associated and cholestatic liver disease and hepatocellular carcinoma, and reviews FXR agonists and FGF19 analogs.
- Evidence
- Emerging
Cite this record: https://thecellwell.org/studies/HH-76284
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.